TVB-009P
AssetAntibodyAlso TVB-009
Monoclonal antibody inhibiting RANKL to reduce bone resorption
- Stage
- Phase 3
- Modality
- Antibody
- Target
- TNFSF11
- Indications
- 1
- Trials
- 1
- Developers
- 1
Indications
1Postmenopausal osteoporosis
Phase 3COMPLETEDNCT04729621clinicaltrials.gov7 Oct 2026
- Targets and what it contains1
- Owner and partners2
- Trials1
- Evidence for its targets1
- Competitors2
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 1 source